David Southwell: CEO of Volastra Therapeutics

from BioBoss · host David Southwell

David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.

What this episode covers

NOW PLAYING

0:00 31:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioBoss?

This episode is 31 minutes long.

When was this BioBoss episode published?

This episode was published on February 28, 2026.

What is this episode about?

Can I download this BioBoss episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!